Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E29.86 EPS (ttm)5.40 Insider Own0.10% Shs Outstand2.63B Perf Week-0.97%
Market Cap429.05B Forward P/E15.63 EPS next Y10.31 Insider Trans-2.01% Shs Float2.61B Perf Month1.32%
Income14.41B PEG3.67 EPS next Q2.33 Inst Own69.90% Short Float0.65% Perf Quarter0.55%
Sales82.58B P/S5.20 EPS this Y-4.20% Inst Trans-0.07% Short Ratio2.12 Perf Half Y9.04%
Book/sh24.04 P/B6.71 EPS next Y8.50% ROA8.90% Target Price185.44 Perf Year12.56%
Cash/sh9.47 P/C17.04 EPS next 5Y8.14% ROE23.40% 52W Range133.65 - 173.65 Perf YTD2.46%
Dividend4.04 P/FCF44.20 EPS past 5Y-0.30% ROI14.60% 52W High-7.14% Beta0.72
Dividend %2.51% Quick Ratio1.00 Sales past 5Y3.30% Gross Margin65.70% 52W Low20.65% ATR2.28
Employees134500 Current Ratio1.20 Sales Q/Q8.30% Oper. Margin20.00% RSI (14)46.75 Volatility1.11% 1.26%
OptionableYes Debt/Eq0.56 EPS Q/Q-56.60% Profit Margin17.80% Rel Volume1.04 Prev Close161.25
ShortableYes LT Debt/Eq0.52 EarningsApr 20 BMO Payout71.20% Avg Volume8.06M Price161.25
Recom1.90 SMA20-0.62% SMA50-0.48% SMA2005.88% Volume0 Change0.00%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Apr-12-21 08:11AM  
07:17AM  
06:33AM  
Apr-11-21 05:00AM  
Apr-10-21 04:13PM  
09:48AM  
06:30AM  
Apr-09-21 11:20PM  
06:34PM  
06:21PM  
05:23PM  
04:33PM  
03:07PM  
01:39PM  
01:25PM  
12:12PM  
11:51AM  
11:46AM  
11:46AM  
10:30AM  
09:55AM  
09:51AM  
09:11AM  
09:09AM  
08:16AM  
07:30AM  
06:27AM  
04:51AM  
02:10AM  
01:30AM  
01:14AM  
Apr-08-21 04:53PM  
03:23PM  
02:59PM  
02:08PM  
01:54PM  
01:23PM  
06:11AM  
05:32AM  
05:26AM  
04:50AM  
02:34AM  
Apr-07-21 09:40PM  
08:00PM  
06:10PM  
04:08PM  
02:05PM  
02:03PM  
01:26PM  
11:01AM  
09:24AM  
05:52AM  
Apr-06-21 09:14PM  
08:00PM  
02:43PM  
01:29PM  
11:09AM  
10:55AM  
08:40AM  
08:00AM  
07:08AM  
06:20AM  
05:23AM  
05:15AM  
05:06AM  
Apr-05-21 07:51PM  
04:14PM  
02:06PM  
01:33PM  
12:51PM  
11:28AM  
10:42AM  
10:13AM  
09:15AM  
08:18AM  
08:05AM  
07:45AM  
07:14AM  
07:05AM  
06:58AM  
06:15AM  
05:37AM  
02:05AM  
Apr-04-21 10:54PM  
01:32PM  
01:27PM  
08:23AM  
06:30AM  
06:01AM  
06:00AM  
12:22AM  
Apr-03-21 10:00PM  
09:04PM  
08:00PM  
07:25AM  
06:30AM  
Apr-02-21 11:45AM  
11:15AM  
09:51AM  
08:14AM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM